Response of BRCA1-mutated gallbladder cancer to olaparib: A case report

被引：3

作者：

Yuan Xie ^{[1
]}

Yan Jiang ^{[2
]}

Xiao-bo Yang ^{[1
]}

An-qiang Wang ^{[1
]}

Yong-chang Zheng ^{[1
]}

Xue-shuai Wan ^{[1
]}

Xin-ting sang ^{[1
]}

Kai Wang ^{[3
]}

Da-Dong Zhang ^{[2
]}

Jia-Jia Xu ^{[2
]}

Fu-gen Li ^{[2
]}

Hai-tao Zhao ^{[1
]}

机构：

[1] Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

[2] Institute of Precision Medicine, 3D Medicines Inc 3. Center for Precision Medicine, Zhejiang University International Hospital

来源：

World Journal of Gastroenterology | 2016年 / 46期

关键词：

BRCA; Mutation; Olaparib; Poly ADP-ribose polymerase inhibitor; gallbladder cancer;

D O I：

暂无

中图分类号：

R735.8 [胆囊、胆道肿瘤];

学科分类号：

100214 ;

摘要：

gallbladder cancer(gbc), although considered as a relatively rare malignancy, is the most common neoplasm of the biliary tract system. the late diagnosis and abysmal prognosis present challenges to treatment. the overall 5-year survival rate for metastatic gbc patients is extremely low. BRC A1 and BRCA2 are the breast cancer susceptibility genes and their mutation carriers are at a high risk for cancer development, both in men and women. Olaparib, an oral poly ADP-ribose polymerase inhibitor, has been approved by the Food and Drug Administration and the European commission for the treatment of ovarian cancer with any BRCA1/2 mutations. the first case of BRCA1-mutated gbc patient who responded to olaparib treatment is reported here.

引用

页码：10254 / 10259

页数：6

共 50 条

[21] Metastatic breast cancer with double heterozygosity for the BRCA1 and BRCA2 genes responding to olaparib: A case report [J].

Shao, Bin ;

Di, Lijun .

ONCOLOGY LETTERS, 2024, 27 (06)

[22] Complete pathological response to olaparib and bevacizumab in advanced cervical cancer following chemoradiation in a BRCA1 mutation carrier: a case report [J].

Montero-Macias, Rosa ;

Koual, Meriem ;

Crespel, Celine ;

Le Frere-Belda, Marie Aude ;

Helene, Helene Blons ;

Huyen-Thu Nguyen-Xuan ;

Garinet, Simon ;

Perkins, Geraldine ;

Balay, Vincent ;

Durdux, Catherine ;

Florin, Marie ;

Pere, Helene ;

Bats, Anne-Sophie .

JOURNAL OF MEDICAL CASE REPORTS, 2021, 15 (01)

[23] Complete pathological response to olaparib and bevacizumab in advanced cervical cancer following chemoradiation in a BRCA1 mutation carrier: a case report [J].

Rosa Montero-Macias ;

Meriem Koual ;

Céline Crespel ;

Marie Aude Le Frére-Belda ;

Hélène Blons Hélène ;

Huyen-Thu Nguyen-Xuan ;

Simon Garinet ;

Géraldine Perkins ;

Vincent Balay ;

Catherine Durdux ;

Marie Florin ;

Hélène Péré ;

Anne-Sophie Bats .

Journal of Medical Case Reports, 15

[24] Therapeutic Targeting of BRCA1-Mutated Breast Cancers with Agents That Activate DNA Repair [J].

Alli, Elizabeth ;

Solow-Cordero, David ;

Casey, Stephanie C. ;

Ford, James M. .

CANCER RESEARCH, 2014, 74 (21) :6205-6215

[25] Maintained complete response to talazoparib in a BRCA-2 mutated metastatic luminal breast cancer: case report and review of literature [J].

Albarran, Victor ;

Chamorro, Jesus ;

Pozas, Javier ;

San Roman, Maria ;

Rosero, Diana Isabel ;

Saavedra, Cristina ;

Gion, Maria ;

Cortes, Alfonso ;

Escalera, Elena ;

Guerra, Eva ;

Lopez Miranda, Elena ;

Fernandez Abad, Maria ;

Martinez Janez, Noelia .

FRONTIERS IN ONCOLOGY, 2023, 13

[26] Potent immunogenicity in BRCA1-mutated patients with high-grade serous ovarian carcinoma [J].

Dai, Ying ;

Sun, Chengdu ;

Feng, Yi ;

Jia, Qingzhu ;

Zhu, Bo .

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (08) :3979-3986

[27] Triple-Action Therapy: Combining Machine Learning, Docking, and Dynamics to Combat BRCA1-Mutated Breast Cancer [J].

Zainulabidin, Ashiru Aliyu ;

Sufyan, Aminu Jibril ;

Thirunavukkarasu, Muthu Kumar .

MOLECULAR BIOTECHNOLOGY, 2024,

[28] Unusual metastasis in BRCA mutated pancreatic cancer while on maintenance Olaparib: Two case reports and review of the literature [J].

Assaf, Irene ;

Mans, Laura ;

Sakr, Rita ;

Verset, Gontran ;

Van Laethem, Jean L. .

EUROPEAN JOURNAL OF CANCER, 2021, 157 :63-67

[29] A case report of a dramatic response to olaparib in a patient with metastatic pancreatic cancer harboring a germline BRCA2 mutation [J].

Wang, Huan ;

Mao, Chenyu ;

Li, Ning ;

Sun, Liping ;

Zheng, Yulong ;

Xu, Nong .

MEDICINE, 2019, 98 (40)

[30] Response to olaparib in metastatic castration-resistant prostate cancer with germline BRCA2 mutation: a case report [J].

Ma, Yi ;

He, Lijie ;

Huang, Qianwen ;

Zheng, Shuang ;

Zhang, Zhiqiang ;

Li, Hongshi ;

Liu, Shuang .

BMC MEDICAL GENETICS, 2018, 19

← 1 2 3 4 5 →